Maeda, Koki http://orcid.org/0000-0001-9083-2588
Imamura, Nobuhiro
Tabata, Keisuke
Morizono, Shoichiro
Tokunaga, Takuya
Takeda, Aya
Kamimura, Go
Masashi, Oniwa
Mizuno, Keiko
Aoki, Masaya
Ueda, Kazuhiro
Article History
Received: 10 April 2024
Accepted: 11 July 2024
First Online: 17 July 2024
Declarations
:
: In this case, the delay in the use of SF6 is crucial for the patient’s outcome. Therefore, the hospital director has granted emergency permission for the off-label use, which has also been acknowledged by the ethics committee. Additionally, the ethics committee has accepted the application for the off-label use that I submitted later. The approval number of SF<sub>6</sub> off-label use is #24010.
: Written informed consent was obtained from the patient for their anonymized information to be published in this article.
: The authors declare no potential competing interest with respect to the research, authorship, or publication of this article.